Marinus' investors include a syndicate of premiere health care and pharmaceutical-focused venture capital investors, company founders and individuals as well as non-profit organizations, providing Marinus with a unique blend of industry support.
Domain Associates, LLC is a venture capital firm focused on health care product opportunities including biopharmaceuticals, medical devices and related businesses. Over its 27 year history, Domain has been involved in the creation of over 250 companies. Its latest venture capital fund is Domain Partners VIII, L.P., which is capitalized at $500 million. Domain is located in Princeton, NJ and in San Diego, CA.
Sofinnova Ventures has over 40 years of experience building healthcare companies into market leaders. With $1.4 billion in committed capital, the firm applies capital and expertise to take companies from inception to exit. Sofinnova closed its life science-focused $440M fund, SVP VIII, in late 2011. The firm's investment team of MDs and PhDs has significant scientific, operational and strategic experience, and specializes in financing later stage clinical products and growth companies. Our team partners with entrepreneurs to address patients' unmet medical needs. Sofinnova Ventures has offices in Menlo Park and La Jolla, California.
Canaan Partners invests in visionary entrepreneurs and provides them the networks, insights and operational guidance required to build high-performance technology and healthcare companies. For 20 years, the partners have taken an active and committed role in the companies in which they invest, and have completed more than 69 mergers and acquisitions and 52 IPOs. With $3 billion under management and a worldwide footprint, the firm's healthcare team is committed to catalyzing the development of biopharmaceutical, medical device, diagnostic and therapeutics companies that are revolutionizing the practice of medicine. Canaan has offices in California, Connecticut, India and Israel.
Foundation Medical Partners
Foundation Medical Partners is an early-stage venture capital firm focused on solving the needs of the health system. The firm focuses on investments in connected health, healthcare information technology, and medical devices.
Founded in 2012, RusnanoMedInvest (RMI) is a venture capital firm created to effect the partnership between the Russian RUSNANO State Corporation and Domain Associates, L.L.C. signed in February 2012. RMI is headquartered in Moscow, Russia. Life sciences Venture capital firm RMI is a subsidiary of RUSNANO, a 100-percent Russian state-owned corporation whose mission is to develop the Russian nanotechnology industry through co-investment in nanotechnology projects with substantial economic potential or social benefit. RMI's key objectives are to advance projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia.